Reuters logo
BRIEF-Key executives in Diamyd Medical to subscribe in full for their shares in the rights issue
May 15, 2017 / 1:43 PM / 4 months ago

BRIEF-Key executives in Diamyd Medical to subscribe in full for their shares in the rights issue

May 15 (Reuters) - DIAMYD MEDICAL AB

* KEY EXECUTIVES IN DIAMYD MEDICAL INTEND TO SUBSCRIBE IN FULL FOR THEIR SHARES IN THE RIGHTS ISSUE

* IS IMPLEMENTING A RIGHTS ISSUE TOTALING APPROXIMATELY MSEK 68.8 BEFORE ISSUE COSTS, AND AN OVER-ALLOTMENT OPTION OF MSEK 20 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below